138 results

Takeda said it offered had £46.50 (€53.46) a share in cash and stock last week for Shire in a bid to extend its global reach.

Shire shares surged following a report that Allergan is considering a bid for the drugmaker to compete with Takeda Pharmaceutical’s $60 billion (€48,(...)

Takeda is not considering purchasing only some businesses or assets, Credit Suisse said in a note. Photograph: Kim Kyung-Hoon/Reuters

Takeda Pharmaceutical chief executive Christophe Weber is contemplating a deal for all of Shire, telling a select audience that size is not an obstacl(...)

Traders work on the floor of the New York Stock Exchange as markets react to a trade dispute between China and the United States. Photograph: Justin Lane/EPA

European shares fell as China’s response to US tariffs fuelled fears of a trade war. DUBLIN The Irish market reflected the rest of Europe. Cider mak(...)

Is Takeda’s pursuit of Irish rare disease drug group Shire over even before it has properly begun? Photograph: Suzanne Plunkett/Reuters

Is Takeda’s pursuit of Irish rare disease drug group Shire over even before it has properly begun? Japan’s largest drugmaker was flushed out into the(...)

Shire said it had not received any formal approach or offer from Takeda Pharmaceutical. Photograph: Suzanne Plunkett/Reuters

Shares of Takeda Pharmaceutical fell the most in nine years after the company disclosed it was considering a bid for Irish pharmaceuticals group Shire(...)

Amazon fell more than 5 per cent after reports that president Donald Trump was looking to target the company by changing its tax treatment.

Shares rose generally yesterday with most European indices bar Germany’s Dax up. Bank of Ireland and AIB rose on news that the Minister for Finance, P(...)

Shire Plc’s offices stand at the Citywest Business Campus in Dublin, Ireland. Photograph: Aidan Crawley / BLOOMBERG

Japan’s largest pharma group Takeda is considering a takeover bid for Irish rare disease specialist Shire. Takeda said Wednesday that its deliberatio(...)

Susan Hynes, Dunboyne site lead for Shire and Dominic Carolan, CEO NIBRT. Photograph: Conor McCabe

Shire, the Ireland-domiciled pharma group that specialises in rare diseases, has signed a training deal with the National Institute of Bioprocessing R(...)

Pfizer, which makes erectile dysfunction treatment Viagra, raised the average wholesale price of 148 drugs by between 6 and 13.5 per cent.

Pharma firms have imposed price rises of several times the rate of inflation on more than 1,000 products in the United States, a new year move that ri(...)

Ryanair rose 1.3% to €15.15 on a day when it  continued to deal with industrial relations tensions

Major global stock markets were little changed on Wednesday, hovering near recent record highs, while US treasury yields held close to multi-month pea(...)

  • « First
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • Next
  • Last »